Pfizer’s hemophilia trial cure shows 92% cut in bleeds
Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating.